StoneX Group’s SPDR S&P Biotech ETF XBI Stock Holding History

StoneX Group’s Portfolio XBI Stock Details XBI Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.85M	Sell	22,324 -2,151	-9%	-$178K	0.09%	191
2025 Q1	$1.98M	Sell	24,475 -2,904	-11%	-$236K	0.11%	177
2024 Q4	$2.47M	Buy	27,379 +21,221	+345%	+$1.91M	0.14%	143
2024 Q3	$608K	Buy	6,158 +40	+0.7%	+$3.95K	0.27%	94
2024 Q2	$567K	Sell	6,118 -2,897	-32%	-$269K	0.27%	97
2024 Q1	$855K	Buy	9,015 +3,500	+63%	+$332K	0.44%	48
2023 Q4	$492K	Sell	5,515 -4,120	-43%	-$368K	0.26%	97
2023 Q3	$704K	Buy	9,635 +1,780	+23%	+$130K	0.39%	65
2023 Q2	$654K	Buy	7,855 +407	+5%	+$33.9K	0.37%	69
2023 Q1	$568K	Sell	7,448 -114	-2%	-$8.69K	0.34%	82
2022 Q4	$628K	Sell	7,562 -3,755	-33%	-$312K	0.09%	179
2022 Q3	$898K	Buy	11,317 +4,190	+59%	+$332K	0.17%	103
2022 Q2	$529K	Sell	7,127 -445	-6%	-$33.1K	0.09%	165
2022 Q1	$681K	Buy	7,572 +340	+5%	+$30.6K	0.06%	260
2021 Q4	$810K	Buy	7,232 +132	+2%	+$14.8K	0.09%	205
2021 Q3	$893K	Sell	7,100 -563	-7%	-$70.8K	0.13%	172
2021 Q2	$1.04M	Buy	7,663 +86	+1%	+$11.6K	0.15%	144
2021 Q1	$1.03M	Sell	7,577 -1,401	-16%	-$190K	0.18%	108
2020 Q4	$1.26M	Buy	8,978 +94	+1%	+$13.2K	0.28%	66
2020 Q3	$990K	Buy	8,884 +1,008	+13%	+$112K	0.32%	72
2020 Q2	$882K	Sell	7,876 -252	-3%	-$28.2K	0.33%	76
2020 Q1	$629K	Buy	8,128 +1,652	+26%	+$128K	0.33%	90
2019 Q4	$616K	Sell	6,476 -252	-4%	-$24K	0.25%	119
2019 Q3	$513K	Buy	6,728 +30	+0.4%	+$2.29K	0.32%	105
2019 Q2	$587K	Sell	6,698 -396	-6%	-$34.7K	0.38%	84
2019 Q1	$642K	Buy	7,094 +58	+0.8%	+$5.25K	0.49%	70
2018 Q4	$505K	Sell	7,036 -1,249	-15%	-$89.6K	0.49%	73
2018 Q3	$794K	Buy	8,285 +394	+5%	+$37.8K	0.59%	50
2018 Q2	$751K	Sell	7,891 -436	-5%	-$41.5K	0.65%	43
2018 Q1	$731K	Buy	8,327 +2,413	+41%	+$212K	0.7%	34
2017 Q4	$502K	Sell	5,914 -1,388	-19%	-$118K	0.52%	57
2017 Q3	$632K	Buy	7,302 +22	+0.3%	+$1.9K	0.79%	36
2017 Q2	$562K	Buy	+7,280	New	+$562K	0.18%	192